mrna stock

MRNA Stock: Moderna Reports Strong Q3 2024 Financial Results, Boosted by Spikevax and RSV Vaccine Sales

MRNA Stock: Moderna, Inc. (NASDAQ: MRNA) has announced its third-quarter financial results for 2024, with total revenues reaching $1.9 billion,…

9 hours ago